Intravenous valproic acid in the treatment of severe catatonia [3]

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 13, Issue 2, 2001, Pages 303-304

  Kruger S ^a   Braunig P ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LORAZEPAM; VALPROIC ACID;

ADULT; CASE REPORT; CATATONIA; DISEASE SEVERITY; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; HUMAN; LETTER; MALE; MOTOR DYSFUNCTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034990903     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.13.2.303     Document Type: Letter

References (6)

1. Clinical and pharmacological risk factors for neuroleptic malignant syndrome: A case-control study
2. Catatonia and the neuroleptics: Psychobiologic significance of remote and recent findings
3. Carbamazepine in the treatment of catatonia
4. The Bräunig catatonia rating scale, I: Development and reliability
5. The GABAa vs. GABAb hypothesis of catatonia
6. Actions of sodium valproate on the central nervous system